Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Zoccolella S et al. | Current and emerging treatments for amyotrophic lateral sclerosis. | 2009 | Neuropsychiatr Dis Treat | pmid:19966906 |
Kasashima S et al. | Androgen receptor and 5alpha-reductase immunohistochemical profiles in extramammary Paget disease. | 2010 | Br. J. Dermatol. | pmid:19995364 |
Verhovshek T et al. | Testosterone metabolites differentially maintain adult morphology in a sexually dimorphic neuromuscular system. | 2010 | Dev Neurobiol | pmid:20024940 |
Shore N | NX-1207: a novel investigational drug for the treatment of benign prostatic hyperplasia. | 2010 | Expert Opin Investig Drugs | pmid:20050813 |
Li L et al. | Selective induction of apoptosis in the hamster flank sebaceous gland organ by a topical liposome 5-alpha-reductase inhibitor: a treatment strategy for acne. | 2010 | J. Dermatol. | pmid:20175850 |
Oh CY et al. | Korean urologist's view of practice patterns in diagnosis and management of benign prostatic hyperplasia: a nationwide survey. | 2010 | Yonsei Med. J. | pmid:20191018 |
Cohen P | Do 5-alpha reductase inhibitors influence the severity of brain injury in men after a stroke? | 2010 | Med. Hypotheses | pmid:20202761 |
Bühler P et al. | Comparison of gene expression in LNCaP prostate cancer cells after treatment with bicalutamide or 5-alpha-reductase inhibitors. | 2010 | Urol. Int. | pmid:20215827 |
Elterman DS et al. | Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. | 2010 | J. Urol. | pmid:20303529 |
Dovbnya DV et al. | Microbial side-chain degradation of ergosterol and its 3-substituted derivatives: a new route for obtaining of deltanoids. | 2010 | Steroids | pmid:20385161 |